Global Ulcerative Colitis Market 2016-2020


#717610

67pages

Technavio

$ 2500

In Stock

About Ulcerative Colitis

Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. Inflammation and ulcers are formed in the innermost lining of the colon and rectum, resulting in the production of pus and mucous. Based on the extent of inflammation and the location, ulcerative colitis can be of different types: ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis or universal colitis, and fulminant colitis. Abdominal cramps, diarrhea, and rectal bleeding are among the common symptoms observed in individuals with the disease. Medications such as 5-aminosalicylates, steroids, purine analogs, immunomodulators, and biologics are used to treat the disease.

Technavios analysts forecast the global ulcerative colitis market to grow at a CAGR of 6.6% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global ulcerative colitis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used to treat ulcerative colitis.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Ulcerative Colitis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AbbVie
Janssen Biotech
Merck
Takeda Pharmaceuticals

Other prominent vendors
Abbott
Ajinomoto Pharmaceuticals
Amgen
Arena Pharmaceuticals
AstraZeneca
Astellas Pharma
Avaxia Biologics
BioLineRx
Celgene
Cosmo Pharmaceuticals
Eisai
Ferring Pharmaceuticals
Galapagos
Genentech
Gilead Sciences
GlaxoSmithKline
Hutchison Medi Pharma
Immune Pharmaceuticals
InDex Pharmaceuticals
Kaken Pharmaceutical
Kissei Pharmaceutical
Kyowa Hakko Kirin
Lipid Therapeutics
Meda
Mitsubishi Tanabe
Mochida Pharmaceutical
Morphotek
Nestl
Pfizer
Procter & Gamble
Qu Biologics
Receptos
Salix Pharmaceuticals
Shield Therapeutics
Shire Pharmaceuticals
Sterna Biologicals
Tillotts Pharma
TopiVert
UCB
Zeria Pharmaceutical

Market driver
Increase in patient assistance programs
For a full, detailed list, view our report

Market challenge
Patent expiries
For a full, detailed list, view our report

Market trend
Rising use of biologics
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.